Evidence map›Paper›PMID 33387523›Full record

ArticleGastroenterology2021

The Path to Gastroenterology and Hepatology Leadership: Inadvertently Perpetuating the Glass Ceiling and Sticky Floor.

Lisa B VanWagner, Rachel B Issaka

Abstract readLetterComment
In one paragraph

Article in Gastroenterology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

2 authors.

Lisa B VanWagnerDepartment of Medicine, Division of Gastroenterology and Hepatology and, Department of Preventive Medicine, Division of Epidemiology, Northwestern University Feinberg School of Medicine, Chicago, Illinois.
Rachel B IssakaClinical Research Division, Fred Hutchinson Cancer Research Center, and, Division of Gastroenterology, University of Washington School of Medicine, Seattle, Washington.

Funding

Developing an intervention to improve follow-up of abnormal fecal immunochemical test results in a safety-net population using a mixed methods approachK08CA241296 · NCI · FRED HUTCHINSON CANCER RESEARCH CENTER · PI ISSAKA, RACHEL B. · 2019 to 2023
$1.1M
Implementation science to improve cardiovascular outcomes among liver transplant recipientsK23HL136891 · NHLBI · NORTHWESTERN UNIVERSITY AT CHICAGO · PI VANWAGNER, LISA B · 2017 to 2020
$757k
NCI NIH HHS K08 CA241296NHLBI NIH HHS K23 HL136891NIMHD NIH HHS L32 MD012892
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

GastroenterologyHumansLeadership

Identifiers

PMID33387523
PMCPMC8215570

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.